Global Genetic Testing For Neurological Disorders Market Research Report 2026(Status and Outlook)
Genetic testing for neurological diseases uses technologies such as gene sequencing to analyze pathogenic variants related to the nervous system in the patient's DNA. It is used to confirm the molecular causes of diseases such as hereditary epilepsy, leukodystrophy, motor neuron disease, and assist in clinical diagnosis, prognosis assessment, and family genetic counseling.
The global Genetic Testing For Neurological Disorders market size was estimated at USD 2835.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Genetic Testing For Neurological Disorders market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Genetic Testing For Neurological Disorders market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Genetic Testing For Neurological Disorders market.
Global Genetic Testing For Neurological Disorders Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Illumina
CENTOGENE
Victorian Clinical Genetics Services
PacBio
Mayo Clinic
Quest Diagnostics
MedGenome Labs
GeneDx
Connecticut Children's
Labcorp (Invitae/MNG Laboratories)
Market Segmentation (by Type)
Exome Sequencing
Whole Genome Sequencing
RNA Sequencing
General DNA Testing
Market Segmentation (by Application)
Hospitals
Specialty Clinics
Diagnostics Laboratories
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Genetic Testing For Neurological Disorders Market
Overview of the regional outlook of the Genetic Testing For Neurological Disorders Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genetic Testing For Neurological Disorders Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Genetic Testing For Neurological Disorders, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Genetic Testing For Neurological Disorders market size was estimated at USD 2835.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Genetic Testing For Neurological Disorders market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Genetic Testing For Neurological Disorders market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Genetic Testing For Neurological Disorders market.
Global Genetic Testing For Neurological Disorders Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Illumina
CENTOGENE
Victorian Clinical Genetics Services
PacBio
Mayo Clinic
Quest Diagnostics
MedGenome Labs
GeneDx
Connecticut Children's
Labcorp (Invitae/MNG Laboratories)
Market Segmentation (by Type)
Exome Sequencing
Whole Genome Sequencing
RNA Sequencing
General DNA Testing
Market Segmentation (by Application)
Hospitals
Specialty Clinics
Diagnostics Laboratories
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Genetic Testing For Neurological Disorders Market
Overview of the regional outlook of the Genetic Testing For Neurological Disorders Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genetic Testing For Neurological Disorders Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Genetic Testing For Neurological Disorders, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Genetic Testing For Neurological Disorders
1.2 Key Market Segments
1.2.1 Genetic Testing For Neurological Disorders Segment by Type
1.2.2 Genetic Testing For Neurological Disorders Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Genetic Testing For Neurological Disorders Product Life Cycle
3.3 Global Genetic Testing For Neurological Disorders Revenue Market Share by Company (2020-2025)
3.4 Genetic Testing For Neurological Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Genetic Testing For Neurological Disorders Market Competitive Situation and Trends
3.6.1 Genetic Testing For Neurological Disorders Market Concentration Rate
3.6.2 Global 5 and 10 Largest Genetic Testing For Neurological Disorders Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GENETIC TESTING FOR NEUROLOGICAL DISORDERS VALUE CHAIN ANALYSIS
4.1 Genetic Testing For Neurological Disorders Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Genetic Testing For Neurological Disorders Market Porter's Five Forces Analysis
6 GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Genetic Testing For Neurological Disorders Market by Type (2020-2025)
6.3 Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Type (2021-2025)
7 GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Genetic Testing For Neurological Disorders Market Size (M USD) by Application (2020-2025)
7.3 Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Application (2021-2025)
8 GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET SEGMENTATION BY REGION
8.1 Global Genetic Testing For Neurological Disorders Market Size by Region
8.1.1 Global Genetic Testing For Neurological Disorders Market Size by Region
8.1.2 Global Genetic Testing For Neurological Disorders Market Size Market Share by Region
8.2 North America
8.2.1 North America Genetic Testing For Neurological Disorders Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Genetic Testing For Neurological Disorders Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Genetic Testing For Neurological Disorders Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Genetic Testing For Neurological Disorders Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Genetic Testing For Neurological Disorders Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Illumina
9.1.1 Illumina Basic Information
9.1.2 Illumina Genetic Testing For Neurological Disorders Product Overview
9.1.3 Illumina Genetic Testing For Neurological Disorders Product Market Performance
9.1.4 Illumina SWOT Analysis
9.1.5 Illumina Business Overview
9.1.6 Illumina Recent Developments
9.2 CENTOGENE
9.2.1 CENTOGENE Basic Information
9.2.2 CENTOGENE Genetic Testing For Neurological Disorders Product Overview
9.2.3 CENTOGENE Genetic Testing For Neurological Disorders Product Market Performance
9.2.4 CENTOGENE SWOT Analysis
9.2.5 CENTOGENE Business Overview
9.2.6 CENTOGENE Recent Developments
9.3 Victorian Clinical Genetics Services
9.3.1 Victorian Clinical Genetics Services Basic Information
9.3.2 Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Product Overview
9.3.3 Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Product Market Performance
9.3.4 Victorian Clinical Genetics Services SWOT Analysis
9.3.5 Victorian Clinical Genetics Services Business Overview
9.3.6 Victorian Clinical Genetics Services Recent Developments
9.4 PacBio
9.4.1 PacBio Basic Information
9.4.2 PacBio Genetic Testing For Neurological Disorders Product Overview
9.4.3 PacBio Genetic Testing For Neurological Disorders Product Market Performance
9.4.4 PacBio Business Overview
9.4.5 PacBio Recent Developments
9.5 Mayo Clinic
9.5.1 Mayo Clinic Basic Information
9.5.2 Mayo Clinic Genetic Testing For Neurological Disorders Product Overview
9.5.3 Mayo Clinic Genetic Testing For Neurological Disorders Product Market Performance
9.5.4 Mayo Clinic Business Overview
9.5.5 Mayo Clinic Recent Developments
9.6 Quest Diagnostics
9.6.1 Quest Diagnostics Basic Information
9.6.2 Quest Diagnostics Genetic Testing For Neurological Disorders Product Overview
9.6.3 Quest Diagnostics Genetic Testing For Neurological Disorders Product Market Performance
9.6.4 Quest Diagnostics Business Overview
9.6.5 Quest Diagnostics Recent Developments
9.7 MedGenome Labs
9.7.1 MedGenome Labs Basic Information
9.7.2 MedGenome Labs Genetic Testing For Neurological Disorders Product Overview
9.7.3 MedGenome Labs Genetic Testing For Neurological Disorders Product Market Performance
9.7.4 MedGenome Labs Business Overview
9.7.5 MedGenome Labs Recent Developments
9.8 GeneDx
9.8.1 GeneDx Basic Information
9.8.2 GeneDx Genetic Testing For Neurological Disorders Product Overview
9.8.3 GeneDx Genetic Testing For Neurological Disorders Product Market Performance
9.8.4 GeneDx Business Overview
9.8.5 GeneDx Recent Developments
9.9 Connecticut Children's
9.9.1 Connecticut Children's Basic Information
9.9.2 Connecticut Children's Genetic Testing For Neurological Disorders Product Overview
9.9.3 Connecticut Children's Genetic Testing For Neurological Disorders Product Market Performance
9.9.4 Connecticut Children's Business Overview
9.9.5 Connecticut Children's Recent Developments
9.10 Labcorp (Invitae/MNG Laboratories)
9.10.1 Labcorp (Invitae/MNG Laboratories) Basic Information
9.10.2 Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Product Overview
9.10.3 Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Product Market Performance
9.10.4 Labcorp (Invitae/MNG Laboratories) Business Overview
9.10.5 Labcorp (Invitae/MNG Laboratories) Recent Developments
10 GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET FORECAST BY REGION
10.1 Global Genetic Testing For Neurological Disorders Market Size Forecast
10.2 Global Genetic Testing For Neurological Disorders Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Genetic Testing For Neurological Disorders Market Size Forecast by Country
10.2.3 Asia Pacific Genetic Testing For Neurological Disorders Market Size Forecast by Region
10.2.4 South America Genetic Testing For Neurological Disorders Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Genetic Testing For Neurological Disorders by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Genetic Testing For Neurological Disorders Market Forecast by Type (2026-2035)
11.1.1 Global Genetic Testing For Neurological Disorders Market Size Forecast by Type (2026-2035)
11.2 Global Genetic Testing For Neurological Disorders Market Forecast by Application (2026-2035)
11.2.1 Global Genetic Testing For Neurological Disorders Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Genetic Testing For Neurological Disorders
1.2 Key Market Segments
1.2.1 Genetic Testing For Neurological Disorders Segment by Type
1.2.2 Genetic Testing For Neurological Disorders Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Genetic Testing For Neurological Disorders Product Life Cycle
3.3 Global Genetic Testing For Neurological Disorders Revenue Market Share by Company (2020-2025)
3.4 Genetic Testing For Neurological Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Genetic Testing For Neurological Disorders Market Competitive Situation and Trends
3.6.1 Genetic Testing For Neurological Disorders Market Concentration Rate
3.6.2 Global 5 and 10 Largest Genetic Testing For Neurological Disorders Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GENETIC TESTING FOR NEUROLOGICAL DISORDERS VALUE CHAIN ANALYSIS
4.1 Genetic Testing For Neurological Disorders Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Genetic Testing For Neurological Disorders Market Porter's Five Forces Analysis
6 GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Genetic Testing For Neurological Disorders Market by Type (2020-2025)
6.3 Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Type (2021-2025)
7 GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Genetic Testing For Neurological Disorders Market Size (M USD) by Application (2020-2025)
7.3 Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Application (2021-2025)
8 GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET SEGMENTATION BY REGION
8.1 Global Genetic Testing For Neurological Disorders Market Size by Region
8.1.1 Global Genetic Testing For Neurological Disorders Market Size by Region
8.1.2 Global Genetic Testing For Neurological Disorders Market Size Market Share by Region
8.2 North America
8.2.1 North America Genetic Testing For Neurological Disorders Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Genetic Testing For Neurological Disorders Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Genetic Testing For Neurological Disorders Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Genetic Testing For Neurological Disorders Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Genetic Testing For Neurological Disorders Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Illumina
9.1.1 Illumina Basic Information
9.1.2 Illumina Genetic Testing For Neurological Disorders Product Overview
9.1.3 Illumina Genetic Testing For Neurological Disorders Product Market Performance
9.1.4 Illumina SWOT Analysis
9.1.5 Illumina Business Overview
9.1.6 Illumina Recent Developments
9.2 CENTOGENE
9.2.1 CENTOGENE Basic Information
9.2.2 CENTOGENE Genetic Testing For Neurological Disorders Product Overview
9.2.3 CENTOGENE Genetic Testing For Neurological Disorders Product Market Performance
9.2.4 CENTOGENE SWOT Analysis
9.2.5 CENTOGENE Business Overview
9.2.6 CENTOGENE Recent Developments
9.3 Victorian Clinical Genetics Services
9.3.1 Victorian Clinical Genetics Services Basic Information
9.3.2 Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Product Overview
9.3.3 Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Product Market Performance
9.3.4 Victorian Clinical Genetics Services SWOT Analysis
9.3.5 Victorian Clinical Genetics Services Business Overview
9.3.6 Victorian Clinical Genetics Services Recent Developments
9.4 PacBio
9.4.1 PacBio Basic Information
9.4.2 PacBio Genetic Testing For Neurological Disorders Product Overview
9.4.3 PacBio Genetic Testing For Neurological Disorders Product Market Performance
9.4.4 PacBio Business Overview
9.4.5 PacBio Recent Developments
9.5 Mayo Clinic
9.5.1 Mayo Clinic Basic Information
9.5.2 Mayo Clinic Genetic Testing For Neurological Disorders Product Overview
9.5.3 Mayo Clinic Genetic Testing For Neurological Disorders Product Market Performance
9.5.4 Mayo Clinic Business Overview
9.5.5 Mayo Clinic Recent Developments
9.6 Quest Diagnostics
9.6.1 Quest Diagnostics Basic Information
9.6.2 Quest Diagnostics Genetic Testing For Neurological Disorders Product Overview
9.6.3 Quest Diagnostics Genetic Testing For Neurological Disorders Product Market Performance
9.6.4 Quest Diagnostics Business Overview
9.6.5 Quest Diagnostics Recent Developments
9.7 MedGenome Labs
9.7.1 MedGenome Labs Basic Information
9.7.2 MedGenome Labs Genetic Testing For Neurological Disorders Product Overview
9.7.3 MedGenome Labs Genetic Testing For Neurological Disorders Product Market Performance
9.7.4 MedGenome Labs Business Overview
9.7.5 MedGenome Labs Recent Developments
9.8 GeneDx
9.8.1 GeneDx Basic Information
9.8.2 GeneDx Genetic Testing For Neurological Disorders Product Overview
9.8.3 GeneDx Genetic Testing For Neurological Disorders Product Market Performance
9.8.4 GeneDx Business Overview
9.8.5 GeneDx Recent Developments
9.9 Connecticut Children's
9.9.1 Connecticut Children's Basic Information
9.9.2 Connecticut Children's Genetic Testing For Neurological Disorders Product Overview
9.9.3 Connecticut Children's Genetic Testing For Neurological Disorders Product Market Performance
9.9.4 Connecticut Children's Business Overview
9.9.5 Connecticut Children's Recent Developments
9.10 Labcorp (Invitae/MNG Laboratories)
9.10.1 Labcorp (Invitae/MNG Laboratories) Basic Information
9.10.2 Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Product Overview
9.10.3 Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Product Market Performance
9.10.4 Labcorp (Invitae/MNG Laboratories) Business Overview
9.10.5 Labcorp (Invitae/MNG Laboratories) Recent Developments
10 GENETIC TESTING FOR NEUROLOGICAL DISORDERS MARKET FORECAST BY REGION
10.1 Global Genetic Testing For Neurological Disorders Market Size Forecast
10.2 Global Genetic Testing For Neurological Disorders Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Genetic Testing For Neurological Disorders Market Size Forecast by Country
10.2.3 Asia Pacific Genetic Testing For Neurological Disorders Market Size Forecast by Region
10.2.4 South America Genetic Testing For Neurological Disorders Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Genetic Testing For Neurological Disorders by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Genetic Testing For Neurological Disorders Market Forecast by Type (2026-2035)
11.1.1 Global Genetic Testing For Neurological Disorders Market Size Forecast by Type (2026-2035)
11.2 Global Genetic Testing For Neurological Disorders Market Forecast by Application (2026-2035)
11.2.1 Global Genetic Testing For Neurological Disorders Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Genetic Testing For Neurological Disorders Market Size by Type (M USD)
Table 4. Global Genetic Testing For Neurological Disorders Market Size by Application
Table 5. Genetic Testing For Neurological Disorders Market Size Comparison by Region (M USD)
Table 6. Global Genetic Testing For Neurological Disorders Revenue (M USD) by Company (2020-2025)
Table 7. Global Genetic Testing For Neurological Disorders Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Testing For Neurological Disorders as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Genetic Testing For Neurological Disorders Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Genetic Testing For Neurological Disorders Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Genetic Testing For Neurological Disorders Market Size by Type (M USD)
Table 22. Global Genetic Testing For Neurological Disorders Market Size (M USD) by Type (2020-2025)
Table 23. Global Genetic Testing For Neurological Disorders Market Share by Type (2020-2025)
Table 24. Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Type (2021-2025)
Table 25. Global Genetic Testing For Neurological Disorders Market Size by Application
Table 26. Global Genetic Testing For Neurological Disorders Market Size by Application (2020-2025) & (M USD)
Table 27. Global Genetic Testing For Neurological Disorders Market Share by Application (2020-2025)
Table 28. Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Application (2021-2025)
Table 29. Global Genetic Testing For Neurological Disorders Market Size by Region (2020-2025) & (M USD)
Table 30. Global Genetic Testing For Neurological Disorders Market Size Market Share by Region (2020-2025)
Table 31. North America Genetic Testing For Neurological Disorders Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Genetic Testing For Neurological Disorders Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Genetic Testing For Neurological Disorders Market Size by Region (2020-2025) & (M USD)
Table 34. South America Genetic Testing For Neurological Disorders Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Genetic Testing For Neurological Disorders Market Size by Region (2020-2025) & (M USD)
Table 36. Illumina Basic Information
Table 37. Illumina Genetic Testing For Neurological Disorders Product Overview
Table 38. Illumina Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Illumina SWOT Analysis
Table 40. Illumina Business Overview
Table 41. Illumina Recent Developments
Table 42. CENTOGENE Basic Information
Table 43. CENTOGENE Genetic Testing For Neurological Disorders Product Overview
Table 44. CENTOGENE Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 45. CENTOGENE SWOT Analysis
Table 46. CENTOGENE Business Overview
Table 47. CENTOGENE Recent Developments
Table 48. Victorian Clinical Genetics Services Basic Information
Table 49. Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Product Overview
Table 50. Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Victorian Clinical Genetics Services SWOT Analysis
Table 52. Victorian Clinical Genetics Services Business Overview
Table 53. Victorian Clinical Genetics Services Recent Developments
Table 54. PacBio Basic Information
Table 55. PacBio Genetic Testing For Neurological Disorders Product Overview
Table 56. PacBio Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 57. PacBio Business Overview
Table 58. PacBio Recent Developments
Table 59. Mayo Clinic Basic Information
Table 60. Mayo Clinic Genetic Testing For Neurological Disorders Product Overview
Table 61. Mayo Clinic Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Mayo Clinic Business Overview
Table 63. Mayo Clinic Recent Developments
Table 64. Quest Diagnostics Basic Information
Table 65. Quest Diagnostics Genetic Testing For Neurological Disorders Product Overview
Table 66. Quest Diagnostics Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Quest Diagnostics Business Overview
Table 68. Quest Diagnostics Recent Developments
Table 69. MedGenome Labs Basic Information
Table 70. MedGenome Labs Genetic Testing For Neurological Disorders Product Overview
Table 71. MedGenome Labs Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 72. MedGenome Labs Business Overview
Table 73. MedGenome Labs Recent Developments
Table 74. GeneDx Basic Information
Table 75. GeneDx Genetic Testing For Neurological Disorders Product Overview
Table 76. GeneDx Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 77. GeneDx Business Overview
Table 78. GeneDx Recent Developments
Table 79. Connecticut Children's Basic Information
Table 80. Connecticut Children's Genetic Testing For Neurological Disorders Product Overview
Table 81. Connecticut Children's Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Connecticut Children's Business Overview
Table 83. Connecticut Children's Recent Developments
Table 84. Labcorp (Invitae/MNG Laboratories) Basic Information
Table 85. Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Product Overview
Table 86. Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Labcorp (Invitae/MNG Laboratories) Business Overview
Table 88. Labcorp (Invitae/MNG Laboratories) Recent Developments
Table 89. Global Genetic Testing For Neurological Disorders Market Size Forecast by Region (2026-2035) & (M USD)
Table 90. North America Genetic Testing For Neurological Disorders Market Size Forecast by Country (2026-2035) & (M USD)
Table 91. Europe Genetic Testing For Neurological Disorders Market Size Forecast by Country (2026-2035) & (M USD)
Table 92. Asia Pacific Genetic Testing For Neurological Disorders Market Size Forecast by Region (2026-2035) & (M USD)
Table 93. South America Genetic Testing For Neurological Disorders Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Middle East and Africa Genetic Testing For Neurological Disorders Market Size Forecast by Country (2026-2035) & (M USD)
Table 95. Global Genetic Testing For Neurological Disorders Market Size Forecast by Type (2026-2035) & (M USD)
Table 96. Global Genetic Testing For Neurological Disorders Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Genetic Testing For Neurological Disorders Market Size by Type (M USD)
Table 4. Global Genetic Testing For Neurological Disorders Market Size by Application
Table 5. Genetic Testing For Neurological Disorders Market Size Comparison by Region (M USD)
Table 6. Global Genetic Testing For Neurological Disorders Revenue (M USD) by Company (2020-2025)
Table 7. Global Genetic Testing For Neurological Disorders Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Testing For Neurological Disorders as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Genetic Testing For Neurological Disorders Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Genetic Testing For Neurological Disorders Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Genetic Testing For Neurological Disorders Market Size by Type (M USD)
Table 22. Global Genetic Testing For Neurological Disorders Market Size (M USD) by Type (2020-2025)
Table 23. Global Genetic Testing For Neurological Disorders Market Share by Type (2020-2025)
Table 24. Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Type (2021-2025)
Table 25. Global Genetic Testing For Neurological Disorders Market Size by Application
Table 26. Global Genetic Testing For Neurological Disorders Market Size by Application (2020-2025) & (M USD)
Table 27. Global Genetic Testing For Neurological Disorders Market Share by Application (2020-2025)
Table 28. Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Application (2021-2025)
Table 29. Global Genetic Testing For Neurological Disorders Market Size by Region (2020-2025) & (M USD)
Table 30. Global Genetic Testing For Neurological Disorders Market Size Market Share by Region (2020-2025)
Table 31. North America Genetic Testing For Neurological Disorders Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Genetic Testing For Neurological Disorders Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Genetic Testing For Neurological Disorders Market Size by Region (2020-2025) & (M USD)
Table 34. South America Genetic Testing For Neurological Disorders Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Genetic Testing For Neurological Disorders Market Size by Region (2020-2025) & (M USD)
Table 36. Illumina Basic Information
Table 37. Illumina Genetic Testing For Neurological Disorders Product Overview
Table 38. Illumina Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Illumina SWOT Analysis
Table 40. Illumina Business Overview
Table 41. Illumina Recent Developments
Table 42. CENTOGENE Basic Information
Table 43. CENTOGENE Genetic Testing For Neurological Disorders Product Overview
Table 44. CENTOGENE Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 45. CENTOGENE SWOT Analysis
Table 46. CENTOGENE Business Overview
Table 47. CENTOGENE Recent Developments
Table 48. Victorian Clinical Genetics Services Basic Information
Table 49. Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Product Overview
Table 50. Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Victorian Clinical Genetics Services SWOT Analysis
Table 52. Victorian Clinical Genetics Services Business Overview
Table 53. Victorian Clinical Genetics Services Recent Developments
Table 54. PacBio Basic Information
Table 55. PacBio Genetic Testing For Neurological Disorders Product Overview
Table 56. PacBio Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 57. PacBio Business Overview
Table 58. PacBio Recent Developments
Table 59. Mayo Clinic Basic Information
Table 60. Mayo Clinic Genetic Testing For Neurological Disorders Product Overview
Table 61. Mayo Clinic Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Mayo Clinic Business Overview
Table 63. Mayo Clinic Recent Developments
Table 64. Quest Diagnostics Basic Information
Table 65. Quest Diagnostics Genetic Testing For Neurological Disorders Product Overview
Table 66. Quest Diagnostics Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Quest Diagnostics Business Overview
Table 68. Quest Diagnostics Recent Developments
Table 69. MedGenome Labs Basic Information
Table 70. MedGenome Labs Genetic Testing For Neurological Disorders Product Overview
Table 71. MedGenome Labs Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 72. MedGenome Labs Business Overview
Table 73. MedGenome Labs Recent Developments
Table 74. GeneDx Basic Information
Table 75. GeneDx Genetic Testing For Neurological Disorders Product Overview
Table 76. GeneDx Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 77. GeneDx Business Overview
Table 78. GeneDx Recent Developments
Table 79. Connecticut Children's Basic Information
Table 80. Connecticut Children's Genetic Testing For Neurological Disorders Product Overview
Table 81. Connecticut Children's Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Connecticut Children's Business Overview
Table 83. Connecticut Children's Recent Developments
Table 84. Labcorp (Invitae/MNG Laboratories) Basic Information
Table 85. Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Product Overview
Table 86. Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Labcorp (Invitae/MNG Laboratories) Business Overview
Table 88. Labcorp (Invitae/MNG Laboratories) Recent Developments
Table 89. Global Genetic Testing For Neurological Disorders Market Size Forecast by Region (2026-2035) & (M USD)
Table 90. North America Genetic Testing For Neurological Disorders Market Size Forecast by Country (2026-2035) & (M USD)
Table 91. Europe Genetic Testing For Neurological Disorders Market Size Forecast by Country (2026-2035) & (M USD)
Table 92. Asia Pacific Genetic Testing For Neurological Disorders Market Size Forecast by Region (2026-2035) & (M USD)
Table 93. South America Genetic Testing For Neurological Disorders Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Middle East and Africa Genetic Testing For Neurological Disorders Market Size Forecast by Country (2026-2035) & (M USD)
Table 95. Global Genetic Testing For Neurological Disorders Market Size Forecast by Type (2026-2035) & (M USD)
Table 96. Global Genetic Testing For Neurological Disorders Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Genetic Testing For Neurological Disorders
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Genetic Testing For Neurological Disorders Market Size (M USD), 2025-2035
Figure 5. Global Genetic Testing For Neurological Disorders Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Genetic Testing For Neurological Disorders Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Genetic Testing For Neurological Disorders Product Life Cycle
Figure 12. Global Genetic Testing For Neurological Disorders Revenue Share by Company in 2025
Figure 13. Genetic Testing For Neurological Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Genetic Testing For Neurological Disorders Revenue in 2025
Figure 15. Value Chain Map of Genetic Testing For Neurological Disorders
Figure 16. Global Genetic Testing For Neurological Disorders Market PEST Analysis
Figure 17. Global Genetic Testing For Neurological Disorders Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Genetic Testing For Neurological Disorders Market Share by Type
Figure 20. Market Share of Genetic Testing For Neurological Disorders by Type (2020-2025)
Figure 21. Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Genetic Testing For Neurological Disorders Market Share by Application
Figure 24. Global Genetic Testing For Neurological Disorders Market Share by Application (2020-2025)
Figure 25. Global Genetic Testing For Neurological Disorders Market Share by Application in 2024
Figure 26. Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Genetic Testing For Neurological Disorders Market Size Market Share by Region (2020-2025)
Figure 28. North America Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Genetic Testing For Neurological Disorders Market Size Market Share by Country in 2024
Figure 30. U.S. Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Genetic Testing For Neurological Disorders Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Genetic Testing For Neurological Disorders Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Genetic Testing For Neurological Disorders Market Share by Country in 2024
Figure 35. Germany Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Genetic Testing For Neurological Disorders Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Genetic Testing For Neurological Disorders Market Size Market Share by Region in 2024
Figure 42. China Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Genetic Testing For Neurological Disorders Market Size and Growth Rate (M USD)
Figure 48. South America Genetic Testing For Neurological Disorders Market Size Market Share by Country in 2024
Figure 49. Brazil Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Genetic Testing For Neurological Disorders Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Genetic Testing For Neurological Disorders Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Genetic Testing For Neurological Disorders Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Genetic Testing For Neurological Disorders Market Share Forecast by Type (2026-2035)
Figure 61. Global Genetic Testing For Neurological Disorders Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Genetic Testing For Neurological Disorders
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Genetic Testing For Neurological Disorders Market Size (M USD), 2025-2035
Figure 5. Global Genetic Testing For Neurological Disorders Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Genetic Testing For Neurological Disorders Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Genetic Testing For Neurological Disorders Product Life Cycle
Figure 12. Global Genetic Testing For Neurological Disorders Revenue Share by Company in 2025
Figure 13. Genetic Testing For Neurological Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Genetic Testing For Neurological Disorders Revenue in 2025
Figure 15. Value Chain Map of Genetic Testing For Neurological Disorders
Figure 16. Global Genetic Testing For Neurological Disorders Market PEST Analysis
Figure 17. Global Genetic Testing For Neurological Disorders Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Genetic Testing For Neurological Disorders Market Share by Type
Figure 20. Market Share of Genetic Testing For Neurological Disorders by Type (2020-2025)
Figure 21. Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Genetic Testing For Neurological Disorders Market Share by Application
Figure 24. Global Genetic Testing For Neurological Disorders Market Share by Application (2020-2025)
Figure 25. Global Genetic Testing For Neurological Disorders Market Share by Application in 2024
Figure 26. Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Genetic Testing For Neurological Disorders Market Size Market Share by Region (2020-2025)
Figure 28. North America Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Genetic Testing For Neurological Disorders Market Size Market Share by Country in 2024
Figure 30. U.S. Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Genetic Testing For Neurological Disorders Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Genetic Testing For Neurological Disorders Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Genetic Testing For Neurological Disorders Market Share by Country in 2024
Figure 35. Germany Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Genetic Testing For Neurological Disorders Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Genetic Testing For Neurological Disorders Market Size Market Share by Region in 2024
Figure 42. China Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Genetic Testing For Neurological Disorders Market Size and Growth Rate (M USD)
Figure 48. South America Genetic Testing For Neurological Disorders Market Size Market Share by Country in 2024
Figure 49. Brazil Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Genetic Testing For Neurological Disorders Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Genetic Testing For Neurological Disorders Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Genetic Testing For Neurological Disorders Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Genetic Testing For Neurological Disorders Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Genetic Testing For Neurological Disorders Market Share Forecast by Type (2026-2035)
Figure 61. Global Genetic Testing For Neurological Disorders Market Share Forecast by Application (2026-2035)
